GlassScriptPhysician profile
Dana M Garner
NPI 1285905315
$2,299.42
in general payments reported to CMS, 2019-2025
23 companies · $606 in 2025
The $606 reported for 2025 was more than what 76% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $655 · 2022: $198 · 2023: $338 · 2024: $502 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,446.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $770.66 | 2022-2025 | Puraply Wound Matrix, Puraply Am, Apligraf |
| Abbvie INC. | $296.62 | 2021-2023 | |
| Surgenex LLC | $208.69 | 2025 | Pellograft, Surmatrix, Ardeograft |
| Integra Lifesciences Corporation | $169.69 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Novo Nordisk INC | $159.70 | 2021 | |
| Mimedx Group, INC. | $110.60 | 2024-2025 | |
| Tactile Systems Technology INC | $89.55 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Nestle Healthcare Nutrition INC. | $80.92 | 2021 | |
| Lilly USA, LLC | $78.79 | 2021 | |
| Microtransponder, INC. | $43.49 | 2023 | |
| Medtronic, INC. | $37.71 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $34.79 | 2021 | |
| Esperion Therapeutics, INC. | $27.77 | 2021 | |
| Amgen INC. | $25.34 | 2021 | |
| Hydrofera LLC | $24.92 | 2024 | Hydrofera Blue |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.28 | 2021 | |
| Insulet Corporation | $20.43 | 2023 | Omnipod |
| Takeda Pharmaceuticals U.S.A., INC. | $20.22 | 2021 | |
| Coloplast Corp | $18.06 | 2024 | |
| Pfizer INC. | $17.56 | 2021 | |
| Amarin Pharma, INC. | $16.50 | 2021 | |
| Phadia US INC. | $12.32 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.